Introduction
============

Phosphatidylinositol polyphosphates function in diverse cellular events. This diversity is facilitated by the variety of sterically distinct compounds generated via phosphorylation of inositol at any or all of its six hydroxyls. These compounds are rapidly synthesized and degraded via kinases, phosphatases, and lipases, and thus are ideal regulatory molecules ([@bib17]; [@bib39]). Phosphatidylinositol polyphosphates regulate cell growth and differentiation ([@bib29]; [@bib53]), cytoskeletal rearrangements ([@bib32]), Ca^2+^ mobilization ([@bib4]), and membrane traffic ([@bib17]; [@bib44]; [@bib40]).

The involvement of phosphatidylinositol polyphosphates in membrane traffic has been demonstrated by the requirement of enzymes that synthesize specific phosphatidylinositol polyphosphates. For example, Ca^2+^-dependent secretory granule exocytosis requires both PEP1 and PEP3 activity ([@bib25]), enzymes that together increase the local concentrations of phosphatidylinositol 4,5-bisphosphate (PtdIns\[4,5\]P~2~)[\*](#fn1){ref-type="fn"} ([@bib33]; [@bib31]). Likewise, synthesis of PtdIns(3)P is required for intracellular membrane transport. Mutations in the yeast phosphatidylinositol 3 kinase, *VPS34*, result in secretion of vacuolar proteins, such as carboxypeptidase Y ([@bib26]; [@bib45]; [@bib48]). Moreover, the lysosomal protein, cathepsin D, requires mammalian Vps34p for proper sorting ([@bib7]; [@bib15]). Thus, the ability to increase the local concentration of these phosphatidylinositol polyphosphates is intrinsic to some intracellular membrane traffic events.

One of the primary roles for phosphatidylinositol polyphosphates in membrane traffic is recruitment of specific proteins to designated regions of membranes. Many of the proteins required for formation of clathrin-coated vesicles, dynamin, the α subunit of AP-2, and synaptojanin, contain PtdIns(4,5)P~2~ binding sites ([@bib30]) and have been shown to bind PtdIns(4,5)P~2~ in vitro ([@bib3]; [@bib2]; [@bib6]). More recently, it has been shown that the epsin homology NH~2~-terminal domains of CALM ([@bib19]) and epsin ([@bib28]) bind PtdIns(4,5)P~2~ as well. Likewise, PtdIns(3)P binds specifically to several proteins required for membrane traffic, including Vac1p, EEA1, and Vps27p. Each of these proteins contains a zinc-binding FYVE finger motif, which specifically binds PtdIns(3)P but not other phosphatidylinositols ([@bib9]; [@bib41]; [@bib50]). PtdIns(3)P is required for recruitment of these proteins to membranes and may also regulate protein function ([@bib42]; [@bib52]; [@bib21]).

The discovery of phosphatidylinositol 3,5-bisphosphate (PtdIns\[3,5\]P~2~) has expanded the list of biologically relevant phosphatidylinositol polyphosphates ([@bib18]; [@bib43]; [@bib61]). In *Saccharomyces cerevisiae*, PtdIns(3,5)P~2~ is a low abundance phosphatidylinositol whose synthesis increases in cells exposed to osmotic stress ([@bib18]). Synthesis of PtdIns(3,5)P~2~ in yeast requires Vps34p, demonstrating that PtdIns(3,5)P~2~ is produced by phosphorylation of PtdIns(3)P ([@bib18]). The subsequent phosphorylation of PtdIns(3)P is catalyzed by Fab1p, the sole phosphatidylinositol (3)P 5-kinase in yeast ([@bib13]; [@bib20]). Unlike *vps34* mutants which are defective in membrane transport from the Golgi region to the vacuole, *fab1* mutants have only a partial defect, demonstrating that PtdIns(3,5)P~2~ and PtdIns(3)P have distinct functions ([@bib62]; [@bib20]).

Phenotypic analysis of two yeast mutants that cannot synthesize PtdIns(3,5)P~2~, *fab1* and *vac7*, suggested that this phospholipid is required for selected vacuole membrane functions ([@bib5]; [@bib20]). The most prominent phenotypes include an enlarged, unlobed vacuole and defects in both vacuole inheritance and acidification. A third mutant, *vac14* shares all of these phenotypes.

Here we present the corresponding wild-type gene, *VAC14*, which encodes a newly discovered protein that, like Fab1p and Vac7p, resides on the vacuole membrane and is required for normal cellular levels of PtdIns(3,5)P~2~. We find that Vac14p is both a general activator and a specific osmotic response regulator of the PtdIns(3)P 5-kinase, Fab1p. Moreover, we show that PtdIns(3,5)P~2~ levels are tightly correlated with vacuole morphology and that this ability to regulate the size and number of vacuole lobes, through increased PtdIns(3,5)P~2~, is a physiological response to a sudden increase in extracellular osmolarity. Furthermore, we find that after exposure to osmotic stress, the cellular levels of PtdIns(3,5)P~2~ increase 16--20-fold. These levels are much higher than previously reported and are similar to the basal levels observed for PtdIns(3)P, PtdIns(4)P, and PtdIns(4,5)P~2~. Together, these findings suggest that PtdIns(3,5)P~2~ may function similarly to PtdIns(3)P and PtdIns(4,5)P~2~ (i.e., by recruiting membrane coat proteins) to regulate a specific vacuole-related membrane-trafficking pathway(s) that is required for the observed changes in vacuole morphology.

Results
=======

Identification of the *VAC14* gene
----------------------------------

The Class III *vac* mutant, *vac14-1*, was isolated via fluorescence-activated cell sorting (for description of approach see [@bib56]). Like *vac7* and *fab1* mutants, *vac14-1* cells are defective in vacuole inheritance, acidification, and morphology. These mutants have a single, unlobed, enlarged vacuole. Frequently, the vacuole spans both the mother and daughter cell resulting in an "open figure eight" vacuole morphology ([@bib5]).

We determined (see Materials and methods) that the *VAC14* open reading frame is YLR386W (sequence deposited by the Yeast Genome Sequencing Project). The *VAC14* 2.64-kb open reading frame encodes a novel polypeptide of 880 amino acids. There are no notable motifs except for a putative transmembrane domain (see below). However, *VAC14* displays a high degree of identity with open reading frames present in other eukaryotic organisms. The two regions of highest identity are near the NH~2~ terminus (residues 1--171) ([Fig. 1](#fig1){ref-type="fig"}, left) and COOH terminus (residues 578--746) ([Fig. 1](#fig1){ref-type="fig"}, right). Both mouse and human sequences matching either end were identified in the corresponding EST databases. Moreover, a human hypothetical protein, FLJ10305, found on chromosome 16, shows a high degree of identity with the COOH-terminal region of Vac14p and its sequence matches human EST sequences. Both the NH~2~- and COOH-terminal ESTs map to human chromosome 16, suggesting that they correspond to the same gene. No obvious Vac14p homologues were found in any of the published bacterial genomes.

###### 

**Proteins with identity to Vac14p exist in higher eukaryotes.** Identical amino acids (black) and similar amino acids (gray) are highlighted. (Left) The NH~2~-terminal sequence of *S. cerevisiae VAC14* and related ORFs were aligned using ClustalW (<http://searchlauncher.bcm.tmc.edu:9331/multi-align/multi-align.html>). Sequences were identified by searching the indicated databases via the BLAST algorithm ([@bib1]). The *C. albicans* sequence was found in the *C. albicans* database (<http://sequence-www.stanford.edu/group/candida/search.html>). ORFs from *S. pombe* (EMBL/GenBank/DDBJ accession no. [CAB08779](CAB08779).1), *A. thaliana* (EMBL/GenBank/DDBJ accession no. [AAD12702](AAD12702).1), *C. elegans* (EMBL/GenBank/DDBJ accession no. [CAB00043](CAB00043).1) and *D. melanogaster* (EMBL/GenBank/DDBJ accession no. [AAF54829](AAF54829).1) were in the GenBank database (<http://www.ncbi.nlm.nih.gov/BLAST>). The *M. musculus* sequence was identified in the mouse EST database (<http://www.ncbi.nlm.nih.gov/BLAST>). The sequence shown is a consensus of two similar ESTs (EMBL/GenBank/DDBJ accession nos. [BE573148](BE573148) and [BF162275](BF162275)). The *H. sapiens* sequence was in the human EST database (<http://www.ncbi.nlm.nih.gov/BLAST>). The consensus sequence of 14 similar ESTs from chromosome 16 (EMBL/GenBank/DDBJ accession nos. [AL527155](AL527155), [AL535971](AL535971), [AL555680](AL555680), [AL556062](AL556062), [BE409891](BE409891), [BE696780](BE696780), [BE728471](BE728471), [BE893810](BE893810), [BE901196](BE901196), [BE937614](BE937614), [BF081182](BF081182), [BF091052](BF091052), [BF325708](BF325708), and [BG107035](BG107035)) is shown. The sequences contain at least 25% global identity and 42% global similarity *to S. cerevisiae VAC14*. (Right) The COOH-terminal sequence of yeast Vac14p and similar ORFs were identified and aligned as in the left sequence. The *M. musculus* sequence is a consensus of 12 similar ESTs (EMBL/GenBank/DDBJ accession nos. [AA036005](AA036005), [AA050423](AA050423), [AA058300](AA058300), [AA276168](AA276168), [AA497446](AA497446), [AA670618](AA670618), [BE862623](BE862623), [BF023070](BF023070), [BF237130](BF237130), [BF720417](BF720417), [BG079707](BG079707), [W09660](W09660)). The *H. sapiens* sequence is hypothetical protein, FLJ10305 found on chromosome 16, deposited in the human genome database (<http://www.ncbi.nlm.nih.gov/genome/seq>). One of the mouse ESTs (clone ID 468926) had been mapped to chromosome VIII (106 cM offset) with an inferred position on human chromosome 16 (16q22.1-qter).
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Chromosomal deletion of *VAC14*
-------------------------------

A heterozygous diploid containing a chromosomal deletion of *VAC14* was created by replacing the *VAC14* open reading frame with *TRP1*. The resulting diploid was sporulated. In all 20 tetrads examined the *TRP1* gene cosegregated with the *vac14* phenotypes. *vac14-*Δ*1* cells are viable and, like *vac14-1*, they display abnormal vacuole morphology ([Fig. 2](#fig2){ref-type="fig"} a), are defective in vacuole inheritance, and have a vacuole acidification defect ([Fig. 2](#fig2){ref-type="fig"} e). *vac14-1* and *vac14-*Δ*1* cells have nearly identical growth rates, with a doubling time that is similar to that of wild-type cells (unpublished data). Because *vac14-1* and *vac14-*Δ*1* behave identically in all tests performed, it is likely that the original *vac14-1* allele is a loss of function mutation.

![***FAB1* supresses the vacuole inheritance, morphology, and acidification defects of *vac14*-Δ*1*.** *vac14*-Δ*1* mutants expressing pRS426 (a and e), *VAC14* on a low copy plasmid (b and f), *FAB1* on a multicopy plasmid (c and g), or *FAB1* from a low copy plasmid (d and h) were labeled with either FM4-64 to visualize vacuole membranes (A) or with 200 μM quinacrine to assess vacuole acidification (B). The photographs were taken with both fluorescence and a low level of transmitted light. Bar, 5 μm.](0201002f2){#fig2}

The growth defects of the double mutants, *vac7-*Δ*1*, *vac14*Δ and *fab1-*Δ*1*, *vac14*Δ were similar to *vac7-*Δ*1*, or *fab1-*Δ*1* mutants alone, consistent with *VAC14*, *VAC7*, and *FAB1* functioning in the same pathway. We were unable to determine whether *VAC7* functions upstream or downstream of *FAB1* or *VAC14* because *VAC7* expressed from either a low-copy or multi-copy plasmid did not suppress the *vac14-1*, *vac14-*Δ*1* or *fab1-*Δ*1* mutant phenotypes ([@bib5]), and neither *FAB1* nor *VAC14* suppressed *vac7-*Δ*1.* However, a similar analysis suggested that *VAC14* functions upstream of *FAB1.* Overexpression of *FAB1* suppressed the vacuolar morphology, inheritance ([Fig. 2, c and d](#fig2){ref-type="fig"}) and acidification defects of the *vac14-*Δ*1* mutant ([Fig. 2, g and h](#fig2){ref-type="fig"}), and the *vac14-1* mutant ([@bib5]). This suppression required the kinase activity of Fab1p since overexpression of a kinase-dead *fab1-D2134R* mutant ([@bib20]) did not suppress the *vac14-*Δ*1* mutant phenotypes (unpublished data). These data suggest that Vac14p may be an activator of Fab1p kinase activity.

Vac14p associates with vacuolar membranes
-----------------------------------------

Antibodies raised to a glutathione *S*-transferase (GST)--Vac14p fusion protein recognized a polypeptide with a molecular weight of ∼99 kD, the predicted molecular weight of Vac14p ([Fig. 3](#fig3){ref-type="fig"} A). (A second, 70-kD polypeptide is nonspecific as it appears in both wild-type and *vac14*-Δ*1* extracts.) The majority of Vac14p was found in a membrane-associated fraction that pelleted at 13,000 *g* (P13) ([Fig. 3](#fig3){ref-type="fig"}). The P13 fraction contains large organelles such as vacuoles, ER, and nuclei. A similar fractionation pattern was observed for other vacuolar proteins, such as Vac8p ([@bib57]) ([Fig. 3](#fig3){ref-type="fig"} C).

![**Vac14p associates with a membrane fraction.** (A) Wild-type and *vac14*-Δ*1* yeast were lysed with glass beads. Equivalent amounts of the cell extracts were separated by SDS-PAGE and transferred to nitrocellulose. Western blot analysis was performed with a 1:5,000 dilution of anti-Vac14p antibody. (B) Whole cell extracts of wild-type were subjected to differential centrifugation. Equivalent amounts were loaded in each lane. Lane 2, total crude extract; lane 3, P13, 13,000 *g* spin pellet; lane 4, S13, supernatant from the 13,000 *g* spin; lane 5, P100, 100,000 *g* spin pellet; and lane 6, S100, the supernatant from the 100,000 *g* spin. Western blot analysis with anti-Vac14 antibodies was performed. The nitrocellulose membrane was reprobed with anti-Vac8 polyclonal rabbit antibodies ([@bib57]) at a 1:5,000 dilution.](0201002f3){#fig3}

Vac14p was present on vacuoles isolated on a Ficoll flotation gradient ([Fig. 4](#fig4){ref-type="fig"} A) and was enriched on purified vacuoles to a similar extent as the vacuolar membrane protein, Pho8p ([Fig. 4](#fig4){ref-type="fig"} B). Sequence analysis of Vac14p revealed a putative transmembrane domain between residues 430 and 451 (determined by PSORT and hydropathy plot analysis). Despite this prediction, Vac14p was peripherally associated with vacuole membranes. Treatments with either 0.1 M Na~2~CO~3~, pH 11.5, 1 M NaCl, or 0.8 M NH~2~OH-solubilized Vac14p, whereas Pho8p was not extracted by any of these treatments ([Fig. 4](#fig4){ref-type="fig"} C).

![**Vac14p is peripherally associated with isolated vacuoles.** (A) Vacuoles from wild-type, *vac14*-Δ*1*, *vac7-*Δ*1,* and *fab1*-Δ*1* were isolated on Ficoll flotation gradients. Equivalent protein amounts were loaded in each lane. Western blot analysis was performed with anti-Vac14 and anti-Vac8p antibodies. The nitrocellulose blot was then reprobed with anti-Pho8p antibodies at a 1:1,000 dilution. (B) Vacuoles were isolated from LWY7235. 35 μg of the total cell extract (lane 2) and increasing amounts of the P13 fraction (lanes 3--7), as well as increasing amounts of vacuoles (lanes 8--13), were loaded onto a 7.5% SDS-polyacrylamide gel. Western blot analyses were performed using polyclonal anti-Vac14p, anti-Pho8p, and anti-Kar2p antibodies. (C) Vacuoles were prepared, divided into six equal aliquots, and treated on ice with one of the following conditions: 0.1 M Na~2~CO~3~, pH 11.5, 1 M NaCl, 0.8 M NH~2~OH, or left untreated. Samples were centrifuged at 100,000 *g* for 1 h at 4°C. The resultant supernatant fractions (S100) were separated and the pellets (P100) were resuspended in 100 μl cytosol cocktail. Equal amounts of each were separated on a 7.5% SDS-PAGE, transferred to nitrocellulose, and probed with anti-Vac14 antibody. The nitrocellulose blots were then reprobed with monoclonal anti-Pho8p antibodies. (D) Equal amounts of protein from total cell extracts were loaded into each lane of a 7.5% SDS-polyacrylamide gel. The proteins were then transferred to nitrocellulose. Western blot analyses were performed using anti-Vac14 antibodies and anti-Vac8p antibodies.](0201002f4){#fig4}

Vac14p was also present in vacuoles isolated from *vac7-*Δ*1* and *fab1-*Δ*1* strains ([Fig. 4](#fig4){ref-type="fig"} A). Thus, defects observed in *vac7-*Δ*1* cells are not due to a gross mislocalization of Vac14p. Interestingly, although *fab1-*Δ*1* cell extracts had normal levels of Vac14p ([Fig. 4](#fig4){ref-type="fig"} D), the vacuoles contained ∼50% less Vac14p than wild-type vacuoles ([Fig. 4](#fig4){ref-type="fig"} A). The decrease of Vac14p on *fab1-*Δ*1* vacuoles was observed in four independent experiments and suggests that Vac14p may physically associate with Fab1p. Since some Vac14p remained associated with vacuoles in the absence of Fab1p, there are likely to be additional proteins that bind Vac14p and help mediate its association with vacuolar membranes. Vac7p is not a candidate because *vac7-*Δ*1* vacuoles contain normal levels of Vac14p. We were unable to detect a direct physical interaction between Vac14p and Fab1p either by yeast two-hybrid, coimmunoprecipitation, or cross-linking experiments. Thus, any interaction is likely to be transient or indirect, and therefore difficult to detect by standard biochemical techniques. Cellular fractionation alone was used to determine Vac14p localization because we were unable to use the goat serum for indirect immunofluorescence.

Proper GFP-Fab1p localization does not depend on Vac7p or Vac14p
----------------------------------------------------------------

Fab1p, like Vac14p, is peripherally associated with vacuolar membranes ([@bib20]). A GFP--Fab1p fusion protein was constructed to visualize Fab1p in various mutant strains. The GFP--Fab1p localized to endosomal and vacuolar membranes in wild-type yeast, *fab1-*Δ*1*, *vac7-*Δ*1*, and *vac14-*Δ*1* mutants ([Fig. 5](#fig5){ref-type="fig"}). This demonstrates that defects in PtdIns(3,5)P~2~ levels in *vac7-*Δ*1* and *vac14-*Δ*1* mutants are not due to Fab1p mislocalization. Moreover, both Vac14p and Fab1p are localized on the vacuole, consistent with Vac14p serving as an activator of Fab1p.

![**GFP-Fab1p is localized to the vacuole membranes in *vac14-*Δ*1* and *vac7-*Δ*1*.** Wild-type (A), *fab1-*Δ*1* (B), *vac14*-Δ*1* (C), and *vac7*-Δ*1* (D) strains expressing GFP-Fab1p from a 2μ plasmid (pRS426) were visualized using fluorescence light combined with low levels of transmitted light. Bar, 8 μm.](0201002f5){#fig5}

An improved method to quantify phosphatidylinositol polyphosphate levels in yeast
---------------------------------------------------------------------------------

Standard methods for analyzing phosphatidylinositol levels in yeast have consisted of lysing cells in acidified chloroform/methanol/HCl with the concomitant extraction of total cellular lipids. We tested this method on wild-type yeast in the absence and presence of osmotic shock and obtained phosphatidylinositol polyphosphate levels similar to those reported previously ([@bib18]; [@bib20]) ([Fig. 6](#fig6){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). However, we also noted that there were substantial fluctuations in the levels of PtdIns(3,5)P~2~ and PtdIns(4,5)P~2~ even in identically prepared samples. Therefore, we adapted a method described for analyzing PtdIns(3,5)P~2~ levels in tissue culture cells, where cells are lysed in 4.5% perchloric acid ([@bib61]). This treatment precipitates most macromolecules, including proteins and lipids. The lipids are then deacylated with methylamine and the released glycero-phospho-inositols are extracted with water. Notably, we obtained significantly higher quantities of the corresponding inositol monophosphates and biphosphates ([Fig. 6](#fig6){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}) with far less variability among identically prepared samples for the inositol bisphosphates. This allowed us to reproducibly detect basal levels of PtdIns(3,5)P~2~, which are ∼15-fold higher than reported previously.

![**Use of 4.5% perchloric acid results in a significantly higher extraction of phosphatidylinositol monophosphates and bisphosphates.** Cells were labeled with myo-\[2-^3^H\]inositol for 12 h at 24°C and exposed to 0.9 M NaCl for 10 min. (A) Cells were lysed with glass beads in 1.5 ml chloroform/methanol/1 N HCl (1:1:1) at room temperature. Phospholipids were extracted in the organic phase and dried under a N~2~ stream. (B) Cells were lysed with glass beads in 0.8 ml of 4.5% perchloric acid. Cell extracts were centrifuged at 14,000 rpm at 4°C to obtain a phospholipid-containing pellet. The phospholipids from both protocols were then deacylated and analyzed by HPLC. An online scintillation counter was used to detect the tritiated compounds. Approximately 3.2 × 10^6^ cpm (A, chloroform/methanol/HC1) and 3.6 × 10^6^ cpm (B, 4.5% perchloric acid) were injected, respectively.](0201002f6){#fig6}

###### Cellular lipid extractions utilizing 4.5% perchloric acid provide a more representative measure of phosphatidylinositol levels

                     PtdIns(3)P   PtdIns(4)P   PtdIns(3,5)P~2~   PtdIns(4,5)P~2~                               
  ------------------ ------------ ------------ ----------------- ----------------- --------- ------- --------- ---------
  4.5% HClO~4~       70 ± 15      100 ± 15     65 ± 10           90 ± 15           65 ± 10   4 ± 1   85 ± 20   70 ± 15
  Chloroform: MeOH   38 ± 5       60 ± 5       43 ± 5            68 ± 3            8 ± 3     ≤1.5    12 ± 5    10 ± 5

Cells were grown in inositol-free media in the presence of 0.01 mCi/ml ^3^H inositol. 0.9 M NaCl was added to half the cultures for 10 min prior to extraction. Cellular lipids were extracted and analyzed as described in Materials and methods. The cpm in each peak was corrected for the total number of cells analyzed by expressing each as a percentage of total cpm eluted. Then these values were normalized to PtdIns(3)P with no salt added for the 4.5% perchloric acid extraction. This peak was 2.0% of the total cpm eluted (80,000 cpm of 4 × 10^6^ total cpm). Values listed as ≤1.5 were areas where no peak above background was detected. The data (mean ± standard deviation) were calculated from results obtained in three independent experiments.

PtdIns(3,5)P~2~ levels rise 20-fold in response to osmotic stress
-----------------------------------------------------------------

Using this improved method we found that osmotic stress results in much higher levels of PtdIns(3,5)P~2~ than reported previously ([Table I](#tbl1){ref-type="table"}). 10 min after exposure to osmotic stress, the levels of PtdIns(3,5)P~2~ and PtdIns(4,5)P~2~ are similar to PtdIns(3)P and PtdIns(4)P levels ([Table I](#tbl1){ref-type="table"}). Although the levels of each of the phosphorylated phosphatidylinositols underwent some change after exposure of the cells to osmotic stress, the change in PtdIns(3,5)P~2~ levels was the most dramatic, with the levels of this lipid rising 16--20-fold ([Tables I](#tbl1){ref-type="table"} and [II](#tbl2){ref-type="table"}). Quantification of the fold increase could not be performed on cells extracted with chloroform methanol HCl because with this method PtdIns(3,5)P~2~ was not detectable in cells grown in the absence of osmotic shock. Moreover, after a 10-min exposure to osmotic stress, ∼8-fold more PtdIns(3,5)P~2~ and 7-fold more PtdIns(4,5)P~2~ were detected in cells lysed with perchloric acid compared with cells extracted with chloroform methanol HCL ([Table I](#tbl1){ref-type="table"}).

###### Class III vac mutants fail to maintain normal levels of PtdIns(3,5)P~2~

                           PtdIns(3)P   PtdIns(3,5)P~2~               
  ------------------------ ------------ ----------------- ----------- -----------
  Wild-type                68 ± 7       100 ± 10          71 ± 18     3.5 ± 1.1
  *fab1-*Δ*1*              126 ± 16     91 ± 3            ≤1.5        ≤1.5
  *vac7-*Δ*1*              145 ± 12     105 ± 2           ≤1.5        ≤1.5
  *vac14-*Δ*1*             120 ± 10     97 ± 12           1.7 ± 0.6   ≤1.5
  *fab1-*Δ*1 vac14-*Δ*1*   141 ± 5      101 ± 4           ≤1.5        ≤1.5

Cells were grown in inositol-free media in the presence of 0.01 mCi/ml ^3^H inositol. 0.9 M NaCl was added to half the cultures for 10 min prior to extraction. Values were obtained as described in [Table I](#tbl1){ref-type="table"} and normalized to PtdIns(3)P no salt in wild-type. This peak was 2.0% of the total cpm eluted (80,000 cpm of 4 ± 10^6^ total cpm). Values listed as ≤1.5 were areas where no peak above background was detected. The data (mean ± standard deviation) were calculated from results obtained in six independent experiments.

Fab1p, Vac7p, and Vac14p are required for steady-state levels of PtdIns(3,5)P~2~ during vegetative growth
---------------------------------------------------------------------------------------------------------

We next reevaluated PtdIns(3,5)P~2~ levels in both *vac7-*Δ*1* and *fab1-*Δ*1*. As reported previously ([@bib20]), there was no detectable PtdIns(3,5)P~2~ in *fab1-*Δ*1*, consistent with Fab1p being the sole 5-kinase that converts PtdIns(3)P to PtdIns(3,5)P~2~ ([Table II](#tbl2){ref-type="table"}). Likewise, no PtdIns(3,5)P~2~ was detected in the *vac7-*Δ*1* mutant. We also observed an elevation in PtdIns(3)P levels in these mutants following osmotic stress (see below).

We next analyzed PtdIns(3,5)P~2~ levels in the *vac14-*Δ*1* mutant. Like *vac7* and *fab1* mutants, in the absence of osmotic stress, no detectable PtdIns(3,5)P~2~ was observed ([Table II](#tbl2){ref-type="table"}). These results suggest that the Class III *vac* mutant phenotypes shared by *vac7*, *fab1*, and *vac14* mutants are due to a deficiency in PtdIns(3,5)P~2~ levels.

*vac14* mutants synthesize low levels of PtdIns(3,5)P~2~ after exposure to osmotic stress
-----------------------------------------------------------------------------------------

Unlike *vac7* and *fab1* mutants, when *vac14-*Δ*1* cells were exposed to 0.9 M NaCl for 10 min, a small amount of PtdIns(3,5)P~2~ was observed (1.7 U) ([Table II](#tbl2){ref-type="table"}). This level is similar to the basal levels detected during vegetative growth (3.5 U), but much lower than the osmotic stress--induced levels (71 U) observed in wild-type cells.

We suspect that low, yet undetectable, levels of PtdIns(3,5)P~2~ are synthesized in *vac14-*Δ*1* cells in the absence of osmotic stress. First, *vac14-*Δ*1* mutants produce PtdIns(3,5)P~2~ during osmotic shock, demonstrating that Fab1p, the phosphatidylinositol (3)P 5-kinase, retains partial activity in the absence of Vac14p. Second, the doubling time of *vac14* cells is similar to that of wild-type cells (unpublished data), in contrast to the greatly reduced growth rate of *fab1*Δ and *vac7*Δ ([@bib62]; [@bib5]). The nearly normal doubling time of *vac14* mutants is likely due to synthesis of small amounts of PtdIns(3,5)P~2~.

Vac14p is required for elevation of PtdIns(3,5)P~2~ in response to osmotic stress
---------------------------------------------------------------------------------

Because overexpression of *FAB1* suppresses the vacuolar defects of the *vac14-*Δ*1* mutant ([Fig. 2](#fig2){ref-type="fig"}), we tested PtdIns(3,5)P~2~ levels in these strains. Expression of *FAB1* from a low- or high-copy plasmid in the *vac14*-Δ*1* mutant brought the levels of PtdIns(3,5)P~2~ from undetectable to nearly the basal levels detected in wild-type cells (2 U) ([Table III](#tbl3){ref-type="table"}). These observations are consistent with Vac14p functioning upstream of Fab1p.

###### 

**Vac14p is required for normal elevation of PtdIns(3,5)P** ~2~ **in response to osmotic stress**

                                  PtdIns(3)P   PtdIns(3,5)P~2~               
  ------------------------------- ------------ ----------------- ----------- -----------
  *vac14-*Δ*1* with pRS426        112 ± 10     100 ± 2           2.4 ± 0.3   ≤1.5
  *vac14-*Δ*1* with *FAB1 CEN*    100 ± 8      92 ± 16           3.2 ± 0.8   2.0 ± 0.3
  *vac14-*Δ*1* with *FAB1* 2μ     84 ± 8       84 ± 8            3.1 ± 0.4   2.1 ± 0.8
  *vac14-*Δ*1* with *VAC14 CEN*   55 ± 3       76 ± 3            28 ± 12     3.2 ± 0.8
  *vac14-*Δ*1* with *VAC14* 2μ    60 ± 16      80 ± 24           33 ± 0.4    3.2 ± 0.8

Cells were grown in inositol free media in the presence of 0.01 mCi/ml ^3^H inositol. 0.9 M NaCl was added to half the cultures for 10 min before extraction. The values were generated as described in [Table II](#tbl2){ref-type="table"} and normalized to wild-type ([Table II](#tbl2){ref-type="table"}). The data (mean ± standard deviation) were calculated from results obtained in four independent experiments.

Notably, *FAB1* expression in *vac14* mutants did not restore the elevation of PtdIns(3,5)P~2~ normally observed in response to osmotic shock. The levels of PtdIns(3,5)P~2~ after osmotic shock in *vac14-*Δ1, or *vac14-*Δ*1* with either a low or high copy *FAB1*, were statistically identical (2.4, 3.2, and 3.1 U, respectively) ([Table III](#tbl3){ref-type="table"}). As a control, *vac14-*Δ*1* with *VAC14* expressed from a low copy plasmid produced 30 U of PtdIns(3,5)P~2~ in response to osmotic shock ([Table III](#tbl3){ref-type="table"}). Thus, Vac14p is required for the normal increase of PtdIns(3,5)P~2~ in response to hyperosmotic stress. The small increase in PtdIns(3,5)P~2~ observed after osmotic shock in the *vac14-1* and *vac14-*Δ*1* mutants is most likely due to an osmotic stress--induced elevation of the biosynthetic precursor, PtdIns(3)P (see below).

Vps34p activity increases in response to osmotic stress
-------------------------------------------------------

As PtdIns(3,5)P~2~ levels rise, one would expect to see an equivalent decrease of the precursor, PtdIns(3)P. In fact, after exposure to osmotic stress, we observed a decrease in PtdIns(3)P in wild-type cells ([Table II](#tbl2){ref-type="table"}). However, our data suggests that the rate of PtdIns(3)P synthesis is elevated. First, in wild-type cells, the decrease in PtdIns(3)P by 32 U is not enough to account for the 71 U increase in PtdIns(3,5)P~2~ ([Table II](#tbl2){ref-type="table"}). Second, if the rate of PtdIns(3)P synthesis rises due to osmotic stress, then one would expect to detect this rise in cells that are blocked in PtdIns(3,5)P~2~ synthesis. Indeed, in *fab1-*Δ*1* and *vac7-*Δ*1* mutants, the levels of PtdIns(3)P after exposure to osmotic stress increased by 35 and 40 U, respectively ([Table II](#tbl2){ref-type="table"}). This suggests that after exposure to osmotic stress, PtdIns(3)P levels increase and are quickly depleted by the rapid production of PtdIns(3,5)P~2~. However, in mutants that cannot synthesize PtdIns(3,5)P~2~, the extra PtdIns(3)P accumulates.

In wild-type cells, the elevation of PtdIns(3)P in response to osmotic stress likely compensates for the rapid conversion of PtdIns(3)P to PtdIns(3,5)P~2~. Lack of a compensatory mechanism would deplete the levels of PtdIns(3)P, which are required for membrane trafficking to the yeast vacuole ([@bib45]). In addition, a rise in PtdIns(3)P in response to osmotic shock might also be responsible for producing an increase in PtdIns(3,5)P~2~, as PtdIns(3)P could directly activate Fab1p or drive the reaction forward by mass action.

Although it is possible that Vac14p might indirectly affect PtdIns(3,5)P~2~ levels by regulating Vps34p activity, our data demonstrate that this is not the case. If Vac14p activated Vps34p, then in a *vac14-*Δ*1*, *fab1-*Δ*1* double knockout there would be little or no PtdIns(3)P accumulation. However, in a *vac14-*Δ*1*, *fab1-*Δ*1* double mutant, the levels of PtdIns(3)P were virtually identical to *fab1-*Δ*1* mutants, with a large accumulation of PtdIns(3)P in the presence of osmotic stress (an elevation of 40 and 35 U, respectively) ([Table II](#tbl2){ref-type="table"}). Thus, while osmotic stress activates Vps34p, Vac14p is not involved in this activation. Moreover, the defects in PtdIns(3,5)P~2~ levels in *vac14-*Δ*1* cells are not indirectly due to reduced PtdIns(3)P production.

Vac14p is an osmotic response activator of Fab1p
------------------------------------------------

The observation that during osmotic stress *vac14* mutants have low levels of PtdIns(3,5)P~2~ and accumulate PtdIns(3)P suggests either of two remaining hypotheses. First, Vac14p may function as an osmotic response activator of Fab1p. In the absence of its activator, Fab1p functions with reduced activity, leading to the accumulation of its substrate, PtdIns(3)P. Alternatively, Vac14p may negatively regulate a phosphatidylinositol 5-phosphatase required for PtdIns(3,5)P~2~ turnover which would also result in accumulation of PtdIns(3)P. Although turnover of PtdIns(3,5)P~2~ might also be achieved through the actions of a phosphatidylinositol 3-phosphatase, a polyphosphatidylinositol phosphatase, and/or lipases, none of these would result in the observed accumulation of PtdIns(3)P.

If Fab1p is activated in response to osmotic stress, then there might be a subset of *fab1* mutants that produce basal levels of PtdIns(3,5)P~2~ but are incapable of further activation. The *fab1-2* mutant displays this phenotype ([@bib13]; [@bib20]). At the permissive temperature (24°C), *fab1-2* had normal levels of PtdIns(3,5)P~2~ during vegetative growth (3.1 U), but after exposure to osmotic shock the elevation in PtdIns(3,5)P~2~ levels was greatly reduced (12 U) compared with wild-type levels (71 U) ([Table II](#tbl2){ref-type="table"}). In addition, overexpression of Vac14p in the *fab1-2* mutant did not increase the levels of PtdIns(3,5)P~2~ produced in response to osmotic shock (8 U) ([Table IV](#tbl4){ref-type="table"}). Moreover, overexpression of Fab1p in *fab1-2* did not fully restore levels of PtdIns(3,5)P~2~ to those seen in wild-type cells (27 instead of 71 U). This suggests that *fab1-2* is incapable of full activation by Vac14p and is partially dominant, perhaps by sequestering Vac14p. Consistent with this hypothesis, simultaneous overexpression of wild-type Fab1p and Vac14p in *fab1-2* resulted in much higher levels of PtdIns(3,5)P~2~ (40 U) ([Table IV](#tbl4){ref-type="table"}).

###### Overexpression of *VAC14* does not enable *fab1-2* to produce elevated levels of PtdIns(3,5)P~2~ after exposure to osmotic stress

                                        PtdIns(3)P   PtdIns(3,5)P~2~            
  ------------------------------------- ------------ ----------------- -------- -----------
  *fab1-2* with pRS426, 423, and 424    165 ± 1      150 ± 10          12 ± 2   3.1 ± 0.3
  *fab1-2* with *FAB1* 2μ               85 ± 1       89 ± 5            27 ± 1   3.1 ± 0.9
  *fab1-2* with *VAC14* 2μ              144 ± 9      122 ± 9           8 ± 2    2.4 ± 0.5
  *fab1-2* with *VAC14* and *FAB1* 2μ   97 ± 1       100 ± 4           40 ± 4   2.8 ± 0.2

Cells were grown in inositol-free media in the presence of 0.01 mCi/ml ^3^H inositol. 0.9 M NaCl was added to half the cultures for 10 min prior to extraction. Cellular lipids were extracted and analyzed as described in Materials and methods. The cpm in each peak was corrected for the total number of cells analyzed by expressing each as a percentage of total cpm eluted. Then these values were normalized to PtdIns(3)P with no salt added in *fab1-2* with *VAC14* and *FAB1* 2μ (which was 2.1% of total cpm eluted; 84,000 cpm of 4 × 10^6^ total cpm). The data (mean ± standard deviation) were calculated from results obtained in three independent experiments.

If Vac14p was the inhibitor of the phosphatidylinositol 5-phosphatase, an increase in PtdIns(3,5)P~2~ would be expected when *VAC14* is overexpressed in *fab1-2* cells. In fact, overexpression of *VAC14* did not elevate the levels of PtdIns(3,5)P~2~ in this strain ([Table IV](#tbl4){ref-type="table"}). Since Vac14p is already present, it is possible that the phosphatidylinositol 5-phosphatase is fully inhibited and thus adding more Vac14p has no effect. However, if this were true, simultaneous overexpression of Vac14p and Fab1p should produce the same levels of PtdIns(3,5)P~2~ as overexpression of Fab1p alone. We observed that simultaneous overexpression of Vac14p and Fab1p in *fab1-2* resulted in 48% more PtdIns(3,5)P~2~ than in *fab1-2* overexpressing only Fab1p ([Table IV](#tbl4){ref-type="table"}). These results strongly suggest that Fab1p and Vac14p act in concert with each other and are consistent with Vac14p functioning as an activator of Fab1p rather than as the negative regulator of a phosphatidylinositol 5-phosphatase.

Levels of PtdIns(3,5)P~2~ regulate vacuolar morphology
------------------------------------------------------

Observations of the dramatic increase in PtdIns(3,5)P~2~ levels combined with our identification of a molecule required for activation of Fab1p strongly suggest that PtdIns(3,5)P~2~ protects yeast from rapid increases in osmolarity. As described below, it is likely that this protection occurs via PtdIns(3,5)P~2~ regulation of vacuole volume. Overproduction of PtdIns(3,5)P~2~ resulted in both an increase in the number and a decrease in size of vacuole lobes ([Fig. 7](#fig7){ref-type="fig"}). In this case, elevation of PtdIns(3,5)P~2~ was achieved in the absence of osmotic stress by simultaneous overexpression of both Vac14p and Vac7p. This resulted in a 70% increase in basal levels of PtdIns(3,5)P~2~, 12 U, instead of 7 U (wild-type expressing the vectors alone). Conversely, a pronounced phenotype in cells with defects in steady-state levels of PtdIns(3,5)P~2~ is an enlarged unlobed vacuole. These observations suggest that PtdIns(3,5)P~2~ levels regulate the surface area to volume ratio of the vacuole by changing the number and size of the vacuole lobes. Note that a sphere of a given diameter can create four spheres with a combined total of half the volume using the same total membrane surface area. Thus, increasing PtdIns(3,5)P~2~ levels in response to osmotic stress may serve to regulate vacuole morphology under conditions when the vacuole loses volume due to loss of water. Consistent with this hypothesis, we found that after a short exposure to hyperosmotic stress, the vacuole morphology of wild-type cells changed to smaller, more highly fragmented vacuoles ([Fig. 8](#fig8){ref-type="fig"}, a and e). However, the vacuole morphology of mutants unable to produce PtdIns(3,5)P~2~ remained largely unchanged ([Fig. 8](#fig8){ref-type="fig"}). This demonstrates that changes in vacuole morphology induced by exposure to osmotic stress are regulated via a molecular mechanism that requires the synthesis of more PtdIns(3,5)P~2~. Moreover, this observation provides the first insight into a physiological consequence of increased PtdIns(3,5)P~2~ production in response to osmotic stress.

![**Simultaneous overexpression of *VAC7* and *VAC14* results in cells with a larger number of vacuole lobes and lobes of smaller size.** Wild-type cells simultaneously expressing *VAC7* and *VAC14* from multicopy plasmids (A) or containing empty vectors, pRS424 and pRS423 (B). Vacuoles were labeled with 80 μM FM4-64. Several fields are shown for each. Bar, 8 μm.](0201002f7){#fig7}

![**PtdIns(3,5)P** ~2~ **is required for osmotic stress induced fragmentation of the vacuole.** Wild-type (a and e), *vac14*-Δ*1* (b and f), *fab1*-Δ*1* (c and g), *vac7*-Δ*1* (d and h) cells were labeled with FM4-64 to visualize vacuole membranes. Cells were incubated in YEPD alone (a--d) or YEPD containing 0.4 M NaCl (e--h) for 10 min. Bar, 8 μm.](0201002f8){#fig8}

Discussion
==========

The discovery of a new biological phosphatidylinositol, PtdIns(3,5)P~2~, and the observation that PtdIns(3,5)P~2~ levels are acutely regulated by osmotic stress poses questions as to how this phospholipid is synthesized, how its cellular levels are regulated, where PtdIns(3,5)P~2~ production and turnover occur, and what functions PtdIns(3,5)P~2~ serves. Biosynthesis of PtdIns(3,5)P~2~ occurs through phosphorylation of PtdIns(3)P by Fab1p, the phosphatidylinositol(3)P 5-kinase ([@bib27]; [@bib51]). Its production also requires Vac7p, a novel vacuolar protein, whose function remains unknown ([@bib5]; [@bib20]). Here we identify Vac14p, which functions in PtdIns(3,5)P~2~ synthesis by regulating Fab1p activity. Localization of Vac14p, Fab1p, and Vac7p, along with observations of the defects exhibited in strains lacking PtdIns(3,5)P~2~, suggests that this lipid is produced and functions at the late endosome and vacuole. The fact that the lipid levels rise 20-fold within 10 min of osmotic stress and cause the vacuole lobes to decrease in size and increase in number suggests that the increasing PtdIns(3,5)P~2~ levels and the concomitant change in vacuole volume may be a first line of defense against a sudden increase in osmolarity of the environment.

Changes in PtdIns(3,5)P~2~ levels could occur either via increased PtdIns(3,5)P~2~ synthesis, negative regulation of PtdIns(3,5)P~2~ turnover, or regulation of both ([Fig. 9](#fig9){ref-type="fig"}). However, analysis of selected *fab1* mutants indicates that up-regulation of PtdIns(3,5)P~2~ synthesis, rather than negative regulation of its turnover, is the major contributor to the osmotic stress--induced increase in PtdIns(3,5)P~2~ levels. First, the *fab1*-*2* mutant produces relatively normal levels of PtdIns(3,5)P~2~ under basal conditions, but is specifically defective in elevation of PtdIns(3,5)P~2~ synthesis in response to osmotic stress ([@bib13], and [Table IV](#tbl4){ref-type="table"}). Second, when expressed in *fab1*Δ, Fab1p homologues from both *Schizosaccharomyces pombe* and mouse produce normal basal levels of PtdIns(3,5)P~2~ ([@bib37]). However, strains expressing these homologues as the sole copy of Fab1p are defective in the osmotic stress--induced elevation of PtdIns(3,5)P~2~. The only difference in these cells is the lack of wild-type Fab1p, and therefore the enzymes responsible for regulating PtdIns(3,5)P~2~ turnover should not be affected. This demonstrates that the dramatic elevation in PtdIns(3,5)P~2~ occurs via activation of Fab1p by accessory factors that are unable to act on the Fab1p homologues.

![**Proposed model for regulation of PtdIns(3,5)P~2~ levels in yeast.** PtdIns(3)P is produced by Vps34p ([@bib45]; [@bib49]) and is phosphorylated by Fab1p to produce PtdIns(3,5)P~2~ ([@bib13]; [@bib20]). Both Vac7p ([@bib20]) and Vac14p are required for normal levels of PtdIns(3,5)P~2~. Although Vac7p is required for conversion of PtdIns(3)P to PtdIns(3,5)P~2~, it is unclear whether Vac7p plays a specific role in the osmotic stress response. Vac14p regulates Fab1p to produce basal levels of PtdIns(3,5)P~2~ during vegetative growth and further stimulates Fab1p activity during osmotic stress. Although osmotic stress activates both Vsp34p and Fab1p, Vac14p activates Fab1p but not Vps34p. Increased levels of PtdIns(3,5)P~2~ may protect cells from osmotic stress by modulating water efflux and ion influx across the vacuole membrane, regulating vacuole membrane fission and retrograde traffic, and possibly via modulation of other downstream targets of PtdIns(3,5)P~2~.](0201002f9){#fig9}

Vps34p activity is also regulated in response to osmotic stress in yeast. First, in wild-type cells there is a relatively small decrease of precursor, PtdIns(3)P, compared with the very large increase in product, PtdIns(3,5)P~2~. Moreover, in *fab1-*Δ*1* and *vac7-*Δ*1* mutants, exposure to osmotic stress produces elevated levels of PtdIns(3)P. Vps34p activity is not regulated by Vac14p, as levels of PtdIns(3)P rise in *fab1-*Δ*1*, *vac14-*Δ*1* double mutants; however, conversion of the additional PtdIns(3)P to PtdIns(3,5)P~2~ is dependent on the presence of Vac14p. Thus, while elevated Vps34p activity may be a prerequisite for elevated PtdIns(3,5)P~2~ levels, the activation of Fab1p via Vac14p is required for the 20-fold increase of PtdIns(3,5)P~2~.

Regulated turnover may also contribute to the control of PtdIns(3,5)P~2~ levels. PtdIns(3,5)P~2~ increases rapidly after osmotic shock and then disappears after 30--60 min ([@bib18]). A concerted increase in the activity of the kinases combined with a delayed increase in the activity of the phosphatase(s) and/or lipase could cause the rapid disappearance of PtdIns(3,5)P~2~ that occurs within such a short period of time. Alternatively, it is possible that regulation of PtdIns(3,5)P~2~ levels may occur solely via regulating Fab1p activity. Identification and characterization of enzymes that turnover PtdIns(3,5)P~2~ will be necessary to determine whether turnover of PtdIns(3,5)P~2~ is regulated as well.

Given that PtdIns(3,5)P~2~ levels rise so dramatically after a short exposure to osmotic stress leads to questions of how a rise in PtdIns(3,5)P~2~ levels could mitigate problems caused by a sudden change in osmolarity. One of the first consequences of exposing yeast to osmotic stress is the loss of water from the cells, producing a hypertonic cytoplasm. This in turn results in loss of water from the vacuole. It is possible that this water release is regulated by PtdIns(3,5)P~2~ through control of a vacuolar-specific water channel. Although a vacuolar aquaporin has not yet been demonstrated in *S. cerevisiae*, at least two aquaporins have been identified, *AQY1* and *AQY2* ([@bib10]; [@bib38]). Either of these may localize, in part, to the vacuole membrane. Further, most plant cells contain both plasma membrane and vacuolar aquaporins ([@bib35]; [@bib36]). These prevent the rapid dehydration and cell lysis that could occur when the osmolarity of the external environment changes. As yeast are exposed to similar fluctuations in their external environment, it is likely that they also have similar mechanisms to regulate both water and ion uptake and exit.

PtdIns(3,5)P~2~ may also regulate a vacuolar ion channel and thereby control the internal osmotic strength of the vacuole lumen. A decrease in ion flux out of the vacuole would help retain water that would otherwise be lost to the cytoplasm. Notably, other phosphatidylinositols have been implicated in the regulation of several types of channels. For instance, PtdIns(4,5)P~2~ serves as a positive regulator of inward-rectifying potassium channels ([@bib27]; [@bib51]). PtdIns(4,5)P~2~ also plays a role in the regulation of TRP channel in *Drosophila* photoreceptors ([@bib23]). Studies on the purified yeast vacuolar ATPase have suggested that this enzyme requires phospholipids for maximal activity ([@bib54]). In addition, the yeast phosphatidylinositol--specific phospholipase C (Plc1p) is required for activation of a plasma membrane ATPase, thus implicating phosphatidylinositol phospholipid metabolism in its regulation ([@bib11]). Importantly, all of the yeast mutants defective in PtdIns(3,5)P~2~ levels are also defective in vacuolar acidification, despite the normal localization of the vacuolar ATPase to the vacuole membrane ([@bib5]). This suggests that PtdIns(3,5)P~2~ may regulate the vacuolar ATPase.

PtdIns(3,5)P~2~ also regulates vacuole membrane fission. In the absence of PtdIns(3,5)P~2~, vacuoles are extremely large and unlobed. In contrast, wild-type vacuoles are complex and contain multiple lobes. In addition, production of elevated levels of PtdIns(3,5)P~2~ in the absence of osmotic stress, by simultaneous overexpression of Vac14p and Vac7p, results in a larger number of smaller vacuolar lobes, consistent with an increase in vacuole membrane fission.

Allowing the vacuole membrane surface area to remain constant during a rapid change in vacuole volume enables cells to adjust to a dynamic environment. Hypo-osmotic stress induced vacuole fusion maintains vacuole membrane surface area in the face of a rapid influx of water into the vacuole ([@bib58]). Conversely, exposure to high osmolarity causes vacuoles in wild-type cells to become smaller and more highly fragmented. In addition, an increase in retrograde vesicle traffic, which requires PtdIns(3,5)P~2~ ([@bib8]), removes a higher proportion of vacuole membranes than vacuole volume. By simultaneously regulating water and ion flux, and increasing vacuolar fission and retrograde traffic, PtdIns(3,5)P~2~ may provide a concerted mechanism to prevent vacuole lysis during osmotic stress.

Materials and methods
=====================

Media, strains, and molecular biology techniques
------------------------------------------------

Yeast extract-peptone-dextrose (YEPD) media, synthetic minimal media with the necessary nutritional auxotrophic supplements, sporulation media, synthetic complete media without inositol, and synthetic media without uracil or inositol ([@bib46]; [@bib45]) were prepared as described. High pH YEPD plates with 1.8 M ethylene glycol contained: 1% yeast extract, 2% Bacto-peptone, 1.5% agar, 2% glucose, 1.8 M ethylene glycol, and 100 mM potassium phosphate (pH 7.6). The last three ingredients were not autoclaved and added separately. The strains used in this study are listed in [Table V](#tbl5){ref-type="table"}.

###### Strains used in this study

  Strains   Genotype                                                                               Source
  --------- -------------------------------------------------------------------------------------- ------------
  RHY6210   *MATα leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 pep4-Δ1137*              [@bib22]
  JBY007    RHY6210 *vac7-1*                                                                       [@bib22]
  LWY7217   *MAT*a *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9*                       [@bib5]
  LWY7213   *MAT*a *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 ade8Δ::HIS3*           [@bib56]
  LWY3143   *MAT*a*/α leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9*                     This study
              *pep4-Δ1137/PEP4 ade8Δ::HIS3/ADE8*                                                   
  EMY119    *MAT*a *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 fab1-2*                [@bib62]
  LWY1527   *MATα leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 vac7Δ::HIS3*             [@bib5]
  LWY2365   LWY7217 *vac14-1*                                                                      [@bib5]
  LWY7235   *MAT*a *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9*                       [@bib5]
  LWY7239   *MAT*α *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9*                       This study
              *ade8Δ::HIS3 pep4-Δ1137*                                                             
  LWY2614   *MAT*a *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 fab1-2 vac14-1*        [@bib5]
  LWY2310   *MAT*α *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 fab1-2 vac7-1*         [@bib5]
  LWY4679   *MAT*α *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 vac7-1 vac14-1*        [@bib5]
  LWY4544   *MAT*α *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 ade8Δ::HIS3 vac14-1*   This study
  LWY4552   *MAT*a *leu2,3-112 ura3-52 his3-*Δ*200 trp1-*Δ*901 lys2-801 suc2-*Δ*9*                 This study
              *ade8*Δ*::HIS3 pep4-*Δ*1137 vac14-1*                                                 
  LWY5177   LWY7235 *vac14Δ::TRP1*                                                                 This study
  LWY5178   *MAT*α *leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 vac14Δ::TRP1*          This study
  LWY2054   LWY7217 *vac7Δ::HIS3*                                                                  This study
  LWY2055   LWY7217 *fab1Δ::LEU2*                                                                  This study
  LWY5956   LWY7235 *fab1Δ::LEU2 vac14Δ::HIS3*                                                     This study
  LWY5942   *MATα leu2,3-112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9*                         This study
              *pep4-Δ1137 vac7Δ::HIS3 vac14Δ::TRP1*                                                

Labeling yeast vacuoles with FM4-64 or quinacrine
-------------------------------------------------

Yeast vacuoles were visualized in vivo by labeling log-phase cells with 80 μM *N*-(3-triethylammoniumpropyl)-4-(*p*-diethyl-aminophenylhexatrienyl) (FM4-64) ([@bib5]; [@bib55]) or with quinacrine ([@bib59]). Cells were viewed with a 100× objective lens on an Olympus BX-60 fluorescence microscope (FM4-64: excitation, 560 nm, dichroic mirror at 595 nm, emission, 630 nm; quinacrine; excitation, 470 nm; dichroic mirror at 495 nm; emission, 425 nm) combined with a low level of transmitted light to reveal cell outlines. Images were captured digitally with a Hamamatsu ORCA CCD camera controlled with IP spectrum software (Scanalytics). Images were processed using Adobe Photoshop™.

Cloning *VAC14*
---------------

*VAC14* was cloned by complementing an inability of *vac14-1* cells to grow in high pH media with ethylene glycol at 33°C ([@bib5]). 12 overlapping clones that complemented the growth and vacuolar morphology defects of *vac14-1* cells were obtained. A 3.9-kb SpeI fragment containing a single complementing open reading frame was identified and partially sequenced. Confirmation that YLR386W (sequence deposited by the Yeast Genome Sequencing Project) is *VAC14* was demonstrated by creating a strain with *LEU2* linked to the wild-type YLR386W locus (see below).

Construction of a strain with *LEU2* integrated adjacent to the *VAC14* locus and a strain with a chromosomal deletion of *VAC14*
---------------------------------------------------------------------------------------------------------------------------------

To construct a *LEU2*-marked strain, a 3.9-kb SpeI fragment containing *VAC14* was subcloned into pRS305 ([@bib47]) (pCB48). This plasmid was linearized with XhoI and transformed into wild-type (LWY7235). PCR with genomic DNA isolated from the transformants ([@bib16]) confirmed that integration occurred at the correct locus. The primers used were 5′-CGCGGCAGTATTGAGGG-3′ (v14A) and the T7 universal primer. Diploid cells were generated by crossing the *LEU2*-marked strain (*VAC14*) with LWY4552 (*leu2,3-112*, *vac14-1*). Of 16 tetrads analyzed, all *LEU2* ^+^ colonies were wild-type, whereas all *leu2* ^−^ cells displayed *vac14-1* phenotypes.

To create a chromosomal deletion of *VAC14*, the 3.9-kb SpeI fragment, containing *VAC14* and both 5′ and 3′ untranslated regions, was subcloned into pRS424 (pCB49). *VAC14* was removed with StyI and BclI and replaced by the PCR-amplified *TRP1* gene (digested with StyI and BamHI). The primers used to amplify *TRP1* were V41 (5′-GCTACCCCTTGGGTC ACCTTACGTACAATCTTG-3′) and V42 (5′-CGGGATCCCACTCAACCCTATCTCGGTC-3′). The resulting plasmid (pCB52) was digested with SpeI and the 2.5-kb fragment (containing the *VAC14* knockout cassette) was transformed into LWY3143. Colony PCR (with the primers v14A; see above) and V43 5′-GACTTGAAATTTTCCTTGC-3′) identified transformants containing *TRP1* at the *VAC14* locus.

Preparation of antibodies to Vac14p
-----------------------------------

A *GST*-*VAC14* chimera was created by subcloning *VAC14* into the IPTG inducible GST vector pET21a ([@bib34]). To introduce the appropriate restriction sites (XmaI at the 5′ end and XhoI at the 3′ end), *VAC14* was amplified using the primers 5′-CGCGCCCCGGGGACCATGGAAAAATCGATTGCC-3′ and 5′-GGGCTCGAGGGGTTATTTTTTTAATTTATCGG-3′. The PCR product was digested and ligated to pET21a and digested with XmaI and SalI. The resulting plasmid (pCB69) was transformed into *Escherichia coli* DE3 cells. The soluble GST--Vac14 fusion protein was isolated on glutathione-Sepharose beads and antibodies were raised in goats (Elmira Biological). Serum was depleted of GST antibodies by passaging over a GST-Affi gel column (Bio-Rad Laboratories) and further purified by passage over a total yeast protein column prepared from *vac14*Δ cells.

Subcellular fractionation and Western blot Analysis
---------------------------------------------------

Yeast cell extracts and subcellular fractionations were performed as described ([@bib5]). Briefly, yeast strains were grown in YEPD media at 24°C to an OD~600~ of 0.6. Cells were harvested, washed with cytosol buffer (20 mM Hepes, pH 6.8, 0.15 M potassium acetate, 10 mM MgCl~2~, and 0.25 M sorbitol), resuspended to ∼100 OD/ml and lysed with glass beads. Cell extracts were centrifuged at 500 *g* at 4°C for 4 min. The S5 supernatants were centrifuged at 13,000 *g* at 4°C for 10 min and the resulting S13 supernatants were centrifuged at 100,000 *g* at 4°C for 1 h. The pellets (P13 and P100) were resuspended in an equal amount of cytosol cocktail as the supernatants. Laemmli sample loading buffer was added to equivalent OD units of each fraction. Samples were heated to 80°C for 10 min before loading onto a 7.5% SDS-polyacrylamide gel. The proteins were transferred to nitrocellulose (ECL High Bond; Amersham Life Science, Piscataway, NJ) in Tris-glycine-methanol transfer buffer at 4°C at 34 V for 20 h.

Detection of Vac14p was performed with goat anti-Vac14 antibodies at a 1:5,000 dilution. Donkey anti--goat IgG-horseradish peroxidase (Jackson ImmunoResearch Laboratories) at 1:5,000 dilution was the secondary antibody. Detection of Pho8p was performed with rabbit anti-Pho8 antibodies at 1:1,000 dilution and of Kar2p with rabbit anti-Kar2 antibodies at 1:1,000 dilution (provided by Dr. R. Piper, University of Iowa, Iowa City, IA). The secondary antibody, goat anti--rabbit IgG-horseradish peroxidase (Bio-Rad Laboratories) was used at 1:5,000 dilution.

Vacuole isolation on a Ficoll gradient
--------------------------------------

Yeast vacuoles were isolated as described previously on discontinuous Ficoll gradients ([@bib12]). Equal micrograms of vacuoles (found as a band at the interface between the 4% and 0% Ficoll) from each strain were separated on a 7.5% SDS polyacrylamide gel, transferred to nitrocellulose, and immunoblotted as described above.

Extraction of Vac14p from the membrane
--------------------------------------

Vacuoles from wild-type (LWY7235) cells were diluted to 1 μg/μl with 0% Ficoll buffer (10 mM Pipes, pH 6.8, 200 mM Sorbitol) and 100 μl aliquots were treated with one of the following conditions: 2% Triton X-100, 1.4 M urea, 0.1 M Na~2~CO~3~, 1 M NaCl, 0.8 M NH~2~OH, or left untreated (buffer added to the appropriate volume). Samples were incubated on ice for 30 min and centrifuged at 100,000 *g* at 4°C for 30 min and the pellets were resuspended with an equal volume as the corresponding supernatant fraction. Equal amounts were analyzed by SDS-PAGE and immunoblotting as described above.

Analysis of GFP-Fab1p in vivo
-----------------------------

GFP was inserted into the FAB1 ORF in pRS426 by homologous recombination. To introduce FAB1 sequences at both the 5′ and 3′ ends, GFP was amplified by PCR from pGOGFP ([@bib14]) using the primers FABGFP-N (5′-GCT CAC ATG TCC GGT CGTCCT CCA CTG GTA CTT CAT CTG TGA TGG GTA AAG GAG AAG AAC TTT TC-3′) and FABGFP-C2 (5′-GCG ACG CAG TGC CGG TCA CGT GAC TTG TTG ATG TCG CTG TTG CGG ATC CCG GGC CCG CGG TAC CGT C-3′). The PCR product and AatII-linearized pRS426-FAB1 were cotransformed into yeast and resultant colonies were screened for GFP fluorescence. The pRS426-GFP-FAB1 plasmid was then transformed into various yeast strains and fluorescence was visualized with the same filter set used for quinacrine.

Analysis of phosphatidylinositols
---------------------------------

Cells were grown in YEPD or synthetic media to an OD~600~ between 0.6 and 0.8. 1 OD~600~ U of cells was harvested, washed, and resuspended in synthetic media lacking inositol. 0.14--0.4 OD~600~ U were used to inoculate 5 ml of media lacking inositol containing 50 μCi of myo-\[2-^3^H\]-inositol. Cells were labeled for 12 h at 24°C, harvested by centrifugation, washed, and resuspended in 100 μl of inositol-free media. For hyperosmotic shock, an equal volume of 1.8 M NaCl was added to cells (for a final concentration of 0.9 M NaCl) and the resulting suspension was incubated at 24°C for 10 min. Then, 800 μl of ice cold 4.5% perchloric acid ([@bib60]) was add to the cells and transferred to 15 ml Falcon tubes containing 0.5 g acid-washed glass beads. Cells were lysed by vortexing on high for 30 s with at least a 30 s rest (repeated 10 times for each). The cell extracts were centrifuged at 14,000 rpm for 10 min at 4°C. The pellets were washed with 1 ml of 100 mM EDTA, centrifuged as described above, and resuspended in 50 μl of sterile distilled deionized water.

The lipids were deacylated by treatment with methylamine ([@bib24]). Briefly, 1 ml of methylamine reagent (10.7% methylamine, 45.7% methanol, 11.4% n-butanol) was added to each and incubated in a 55°C heat block for 1 h. The samples were dried in a SpeedVac and the pellets were resuspended in 300 μl of sterile water. The samples were centrifuged at 14,000 rpm for 2 min and the supernatants were transferred to new Eppendorf tubes. 300 μl of butanol/ethyl ether/formic acid ethyl ester (20:4:1) was added to each. The samples were vortexed and centrifuged at 14,000 rpm for 2 min. The aqueous phase (bottom layer) was transferred to new tubes and the extraction was repeated. At the end of the second extraction the aqueous phase was dried in a SpeedVac. Samples were resuspended in 20 μl of sterile water and 10 μl of each was analyzed by HPLC using an anion exchange, PartisphereSAX (Whatman), column. The column was developed with a gradient of 1 M (NH~4~)~2~HPO~4~, pH 3.8 (pH adjusted with phosphoric acid): 1% for 5 min, 1--20% over 44 min, 20--50% over 3.75 min, and remained at 50% for 8 min; the flow rate used was 1.0 ml/min ([@bib45]; [@bib48]).

For comparison of phosphatidylinositol polyphosphate levels, the raw cpms in each peak were expressed as a percentage of the total cpms eluted (phosphatidylinositol is ∼90% of the total ^3^H phosphatidylinositols, whereas phosphatidylinositol polyphosphates are a small percentage, 0.1--3%). The level of PtdIns(3)P identified in the absence of osmotic stress was assigned a value of 100 U; the levels of the other phosphatidylinositol polyphosphates were expressed relative to this value.
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